The wave [4] triangle in IBB is complete, signaling a major buying opportunity. The following move is an impulsive post-triangle thrust, often very strong. Currently, wave 1 of [5] is underway, ...

Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the ...

Scientists at Oak Ridge National Laboratory and the University of Colorado Boulder used a gene-silencing tool and a large ...

As a descendant of an Indigenous Amazonian tribe, Maria Astolfi was concerned about research she conducted as a graduate ...

Me’s bankruptcy could put millions of Americans’ genomic profiles at risk of being sold to the Chinese Communist Party, who ...

U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...

Maintaining physical health as a body ages is an important consideration, and often one of the first things that comes to ...

PITTSBURGH, May 06, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) today reported financial results for the first quarter ending March 31, 2025 and provided a business ...

Vice-president JD Vance has said there is a ‘good chance’ a deal could be reached soon, but what are the red lines, and will ...

XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen ...

Sarepta has submitted a request to the FDA to include the death case in Elevidys’ label, and the agency plans to review the ...